Water Island Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Other funds holding GBT
Water Island Capital's GBT Position: Q4 2022 in Review
Water Island Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 649,242 shares — an estimated $44.2M sold.
Water Island Capital first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $44.2M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Water Island Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Water Island Capital sold 649,242 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $44.2M.
- Water Island Capital first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
- Water Island Capital's Global Blood Therapeutics, Inc. position peaked at $44.2M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Water Island Capital's 13F filing for Q4 2022, filed 14 Feb 2023.